The Nobel prize in physiology or medicine for 2022 has been awarded to Svante Pääbo from the Max Planck Institute for Evolutionary Anthropology in Leipzig, Germany, “for his discoveries concerning the genomes of extinct hominins and human evolution”.
In other words, Pääbo has been awarded the prestigious prize for having sequenced the genomes of our extinct relatives, the Neanderthals and Denisovans, and for the fact that these discoveries have resulted in novel insights into human evolution.
BREAKING NEWS:
The 2022 #NobelPrize in Physiology or Medicine has been awarded to Svante Pääbo “for his discoveries concerning the genomes of extinct hominins and human evolution.” pic.twitter.com/fGFYYnCO6J— The Nobel Prize (@NobelPrize) October 3, 2022
Pääbo is widely regarded as having pioneered the field of ancient DNA, a research area dedicated to the recovery and analysis of DNA from historic and prehistoric remains.
Although Pääbo did his PhD in medical science at Uppsala University in Sweden in the early 1980s, he also studied Egyptology when he was at Uppsala. It was a logical next step that he took tools from molecular biology, garnered from his expertise in medical science, to better understand human prehistory.
Extracting DNA from ancient bones
Beginning in the 1980s, Pääbo studied ancient DNA in material ranging from mummified humans to extinct ground sloths. This work was technically challenging because ancient DNA is significantly degraded and can be contaminated.
In the decade that followed, he developed a series of methods and guidelines to recover and interpret authentic DNA and to minimise the risk of contamination from modern sources, especially from contemporary humans.
In the early 1990s, there was significant excitement in the field about the possibility of recovering DNA from dinosaurs. However, based on his knowledge of how DNA degrades over time, Pääbo remained sceptical that DNA could survive such a long time. He was later proven right.
For many of his colleagues, it was clear that Pääbo’s goal was always to recover Neanderthal DNA. But he took his time and carefully developed the methods for recovering and authenticating ancient DNA until these methods were mature enough to accomplish this objective.
Finally, in 1997, Pääbo and his colleagues published the first Neanderthal DNA sequences. In 2010 this was followed by the entire Neanderthal genome (that is, all the genetic information stored in the DNA of one Neanderthal).
Only a few years later, the group also published the genome from a previously unknown type of human, the Denisovans, distantly related to Neanderthals. This sequencing was based on a 40,000-year-old fragment of bone discovered in the Denisova cave in Siberia.
By virtue of being able to compare these with human genomes, one of the most important findings of Pääbo’s work has been that many modern humans carry a small proportion of DNA from Neanderthals and Denisovans. Modern humans picked up these snippets of DNA through hybridisation, when modern and archaic humans mixed, as modern humans expanded across Eurasia during the last ice age.
For example, particular Neanderthal genes affect how our immune system reacts to infections, including COVID-19. The Denisovan version of a gene called EPAS1, meanwhile, helps people survive at high altitudes. It’s common among modern-day Tibetans.
At the same time, in comparing the genomes of Neanderthals and Denisovans with those of modern humans, Pääbo and his colleagues have been able to highlight genetic mutations that are not shared. A large proportion of these are connected to how the brain develops.
By revealing genetic differences that distinguish living humans from our extinct ancestors, Pääbo’s influential discoveries provide the basis for exploring what makes us uniquely human.
- is a Professor in Evolutionary Genetics, Centre for Palaeogenetics, Stockholm University
- is a Professor in Molecular Archaeology, Department of Archaeology and Classical Studies, Stockholm University
- This article first appeared on The Conversation
